Indoco Remedies has secured final USFDA approval for its generic Lacosamide oral solution, a bioequivalent of Vimpat, enabling the company to market this essential epilepsy treatment in the US from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results